Ehlers-Danlos-syndrome;Ehlers-Danlos-syndrom

Hautarzt

Volumn 50, Issue 4, 1999, Pages 257-265

  Brinckmann, Jürgen ^a   Behrens, Peter ^b   Brenner, Rolf ^b   Bätge, Boris ^b   Tronnier, Michael ^b   Wolff, Helmut H ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b NONE

Author keywords

Collagen; Connective tissue; Ehlers Danlos syndrome

Indexed keywords

COLLAGEN TYPE 3; PROCOLLAGEN LYSINE 2 OXOGLUTARATE 5 DIOXYGENASE;

CHROMATOGRAPHY; CONNECTIVE TISSUE; EHLERS DANLOS SYNDROME; GENE MUTATION; HUMAN; PATHOGENESIS; REVIEW; SYNDROME DELINEATION; WOUND HEALING;

EHLERS-DANLOS SYNDROME; HUMANS;

EID: 0032899790     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050898     Document Type: Review

References (39)

1. Açil Y, Vetter U, Brenner R, Müller PK, Brinckmann J (1995) Diagnosis of Ehlers-Danlos syndrome type VI: cross-link pattern in tissue und urine sample as a diagnostic marker. J Am Acad Dermatol 33:522-524
2. Arneson MA, Hammerschmidt DE, Furch LT, King RA (1980) A new form of Ehlers-Danlos syndrome: fibronectin corrects defective platelet function. JAMA 244:144-147
3. Beighton P (168) X linkel recessive inherited in the Ehlers-Danlos syndrome. Br Med J 111:409-411
4. Beighton P, De Paepe A, Danks D, Finidori G, Gedde-Dahl T, Goodman R, Hall JG, Hollister W, Mc Kusick VA, Opitz JM, Pope FM, Pyeritz RE, Rimoin DL, Sillence D, Spranger JW, Thompson E, Tsipouras P, Viljoen D, Whinship I, Young I (1988) International nosology of heritable disorders of connective tissue, Berlin 1986. Am J Med Genet 29:581-594
5. Byer PH, Siegel RC, Holbrook KA, Narayanan P, Hall JG (1980) X-linked cutis laxa: defective collagen cross-link formation due to decreased lysyl oxidase activity. N Engl J Med 303:61-65
6. Byers PH (1994) Ehlers-Danlos syndrome: recent advances and current understanding of the clinical and genetic heterogeneity. J Invest Dermatol 103:47s-52s
7. Byers PH (1995) Ehlers-Danlos syndrome type IV: a genetic disorder in many guises. J Invest Dermatol 105:311-313
8. De Paepe A, Nuytinck L, Hausser I, Anton-Lamprecht I, Naeyaert JM (1997) Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II. Am J Hum Genet 60:547-554
9. De Paepe A (1994) Ehlers-Danlos syndrome type IV. Dermatology 189 [Suppl 2]:21-25
10. Dyne KM, Zanaboni G, Annoni G, de Agostini MP, Cetta G (1989) Low levels of serum type III procollagen aminoterminal propeptide confirmed type III collagen deficiency in patients without typical clinical symptoms of Ehlers-Danlos type IV. Eur J Clin Invest 19:362-366
11. Elsas LJ, Miller RL, Pinnel SR (1978) Inherited human collagen lysyl hydroxylase deficiency: ascorbic acid reponse. J Pediatr 92:378-384
12. Eyre DR, Shapiro FD, Aldridge JG (1985) A heterozygous collagen defect in a variant of the Ehlers-Danlos syndrome type VII. Evidence fora deleted amino-telopeptide domain in the pro-α2(1) chain. J Biol Chem 260:11322-11329
13. Fujimoto A, Wilcox WR, Cohn DH (1997) Clinical, morphological, and biochemical phenotype of a new case of Ehlers-Danlos syndrome type VIIC. Am J Med Genet 68:25-28
14. Greenspan DS, Nothrup H, Au KS, Mc Allister KA, Francomano CA, Wenstrup RJ, Marchuk DA, Kwiatkowski DJ ( 1995) Fine genetic mapping and exclusion as candidate gene in families with nail-patella syndrome, tuberous sclerosis I, hereditary hemorrhagic teleangiectasia, and Ehlers-Danlos syndrome type II. Genomics 10:737-739
15. Hausser I, Anton-Lamprecht I (1994) Differential ultrastructural aberrations of collagen fibrils in Ehlers-Danlos syndrome types I-IV as a means of diagnostic and classification. Hum Genet 3:394-407
16. Hautala T, Heikkinen J, Kivirikko KI, Myllylä R (1993) A large duplication in the gene for lysyl hydroxylase accounts for the type VI variant of Ehlers-Danlos syndrome in two siblings. Genomics: 15:399-404
17. Heikkinen J, Toppinen T, Yeowell H, Krieg T, Steinmann B, Kivirikko KI, Myllyla R (1997) Duplication of seven exons in the lysyl hydroxylase gene is associated with longer forms of a repetitive sequence within the gene and is a common cause for the type VI variant of Ehlers-Danlos syndrome. Am J Hum Genet 60:48-56
18. Holbrook KA, Byers PH (1989) Skin as a window on heritable disorders of connective tissue. Am J Med Genet 88:105-121
19. Kivirikko KI, MyllIylä R (1984) Biosynthesis of the collagens. In: Piez KA, Reddi AH (eds) Extracellular matrix biochemistry. Elsevier, NewYork, pp 1-39
20. Krane SM, Pinnell SR, Erbe RW (1972) Lysyl-protocollagenhydroxylase deficiency in fibroblasts from siblings with hydroxylysine-deficient collagen. Proc Natl Acad Sci 69:2899-2903
21. Kuivaniemi H, Peltonen L, Palozi A, Kaitila I, Kivirkko KI (1982) Abnormal copper metabolism and deficient lysyl oxidase activity in a heritable connective tissue disorder. J Clin Invest 69:730-733
22. Lehmann HW, Mundlos 5, Winterpacht A, Brenner RE, Zabel B, Müller PK (1994) Ehlers-Danlos syndrome type VII: phenotype and genotype. Arch Derm Res 286:425-428
23. Loughlin J, Irven C, Harwick LJ, Butcher S, Walsh S, Wordsworth P, Sykes B (1995) Linkage of the gene that encodes for the α1-chain of type V collagen (COL5A1) to type Il Ehlers-Danlos syndrome (EDS II). Hum Mol Genet 4:1649-1651
24. McKusick VA (1983) Mendelian inheritance in man. Catalogs of autosomal dominant, autosomal recessive, and X-linked phenotypes, 6th ed. John Hopskin University Press, Baltimore
25. Nicholls AC, Oliver JE, McCarron S, Harison JB, Greenspan DS, Pope FM (1996) An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome. J Med Genet 33:940-946
26. Pope FM, Narcisi P, Nocholls AC, Germaine D, Pals G, Richards AJ (1996) Col3A1 mutations cause variable clinical phenotypes including acrogeria and vascular rupture. Br J Dermatol 135:163-181
27. Reiser K, McCormick RJ, Rucker RB (1992) Enzymatic and nonenzymatic cross-linking of collagen and elastin. FASEB J 6:2439-2449
28. Robins SP, Black D, Paterson CR, Reid DM, Duncan A, Seibl MJ (1991) Evaluation of urinary hydroxypyridinium cross-link measurements as resorption markers in metabolic bone diseases. Eur J Clin Invest 21:310-315
29. Siegel RC, Black CM, Bailey AJ (1979) Cross-linking of collagen in the X-linked Ehlers-Danlos syndrome type V. Biochem Biophys Res Commun 88:281-287
30. Smith LT, Wertelecki W, Milestone LM, Perry EM, Seashore MR, Braverman IM, Jenkins TG, Byers PH (1992) Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen. Am J Hum Genet 51:235-244
31. Sokolov BP, Prytkov AN, Tromp G, Knowlton RG, Prockop DJ (1991) Exclusion of COL1A1, COL1A2, and COL3A1 genes as candidate genes for Ehlers-Danlos syndrome type I in one large family. Hum Genet 88:125-129
32. Steinmann B, Gitzelmann R, Vogel A, Grant ME, Harwood R, Sear CHJ (1975) Ehlers-Danlos syndrome in two siblings with deficient lysyl hydroxylase activity in cultured skin fibroblasts but only mild hydroxylysine deficient skin. Helv Paediatr Acta 30:255-274
33. Steinmann B, Judermann L, Peltonen L, Martin GR, McKusick VA, Prockop DJ (1980) Evidence for a structural mutation of procollagen type I in a patient with the Ehlers-Danlos syndrome type VII. J Biol Chem 255:8887-8893
34. Steinmann B, Superti-Furga A, Joller-Jemelka H, Cetta G, Byers PH (1989) Ehlers-Danlos syndrome type IV: a subset of patients distinguished by low serum levels of the amino-terminal propeptide of type III procollagen. Am J Med Genet 34:68-71
35. Steinmann B, Royce PM, Superti-Furga A (1993) The Ehlers-Danlos syndrome. In: Royce PM, Steinmann B (eds) Connective tissue and its heritable disorders. Wiley-Liss, New York, pp 351-407
36. Wirtz MK, Glanville RW, Steinmann B, Rao VH, Hollister DW (1987) Ehlers-Danlos syndrome type VIIB. Deletion of 18 amino acids comprising the N-telopeptide region of a proα2(1) chain. J Biol Chem 262:16376-16385
37. Wordsworth BR, Oglivie DJ, Sykes BC (1991) Segregation analysis of the structural genes of the major fibrillar collagens provides further evidence of molecular heterogeneity in type Il Ehlers-Danlos syndrome.
38. Yeowell HN, Pinnell SR (1993) The Ehlers-Danlos syndrome. Semin Dermatol 12:229-240
39. Yeowell HN, Walker LC, Marshall MK, Murad S, Pinnell SR (1995) The mRNA and the activity of lysyl hydroxylase are upregulated by the administration of ascorbate and hydralazine to human skin fibroblasts from a patient with Ehlers-Danlos syndrome type Vi. Arch Biochem Biophys 321:510-516